Innovative Drug Delivery Technology

搜索文档
Branded Legacy, Inc. Announces Provisional Patent Filing by BioLegacy for Disruptive Air-Driven Intranasal Platform Targeting Multi-Billion-Dollar Global Therapeutics Market
Globenewswire· 2025-09-30 12:30
Revolutionary platform aims to make life-saving overdose reversal therapies more affordable, accessible, and effective worldwideVANCOUVER, British Columbia, Sept. 30, 2025 (GLOBE NEWSWIRE) -- via IBN -- Branded Legacy, Inc. (OTC: BLEG), a dynamic holding company focused on innovative life sciences and wellness solutions, is thrilled to announce that its subsidiary, BioLegacy Evaluative Group Inc. ("BioLegacy"), has filed a provisional patent application with the United States Patent and Trademark Office (US ...